Klemens Budde

Active 1989–2026

220
Papers
24,268
Citations
87
h-index
189
i10-index

Citations

Citations per year for Klemens Budde1990: 1 citations1991: 3 citations1992: 9 citations1993: 5 citations1994: 3 citations1995: 3 citations1996: 2 citations1997: 2 citations1998: 1 citations2000: 5 citations2001: 17 citations2002: 33 citations2003: 32 citations2004: 70 citations2005: 65 citations2006: 87 citations2007: 86 citations2008: 68 citations2009: 86 citations2010: 79 citations2011: 115 citations2012: 101 citations2013: 120 citations2014: 132 citations2015: 177 citations2016: 173 citations2017: 138 citations2018: 140 citations2019: 508 citations2020: 518 citations2021: 674 citations2022: 698 citations2023: 423 citations2024: 880 citations2025: 414 citations2026: 13 citations1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,696 citing papers, 20.3% of this breakdownGermany: 761 citing papers, 9.1% of this breakdownUnited Kingdom: 513 citing papers, 6.2% of this breakdownFrance: 488 citing papers, 5.9% of this breakdownNetherlands: 437 citing papers, 5.2% of this breakdownChina: 427 citing papers, 5.1% of this breakdownItaly: 413 citing papers, 5% of this breakdownCanada: 359 citing papers, 4.3% of this breakdownSpain: 311 citing papers, 3.7% of this breakdownAustralia: 308 citing papers, 3.7% of this breakdownBelgium: 253 citing papers, 3% of this breakdownSwitzerland: 241 citing papers, 2.9% of this breakdown
0%20.3%Other 25.6%

Fields

  • Medicine76.7%
  • Biochemistry, Genetics and Molecular Biology12.5%
  • Immunology and Microbiology3.1%
  • Computer Science2.3%
  • Pharmacology, Toxicology and Pharmaceutics1.4%
  • Agricultural and Biological Sciences1.2%
  • Other2.8%

Topics

  • Renal Transplantation Outcomes and Treatments10.7%
  • Renal Diseases and Glomerulopathies3.9%
  • Tuberous Sclerosis Complex Research3.4%
  • Transplantation: Methods and Outcomes3.2%
  • Organ Transplantation Techniques and Outcomes2.9%
  • SARS-CoV-2 and COVID-19 Research1.8%
  • Other74.1%

Coauthors

All papers

Open in search
  1. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moncef Berhouma, John J. Bissler, Klemens Budde, Anna W. Byars, Harry T. Chugani, Edward W. Cowen, Peter B. Crino, Paolo Curatolo, Thomas N. Darling, Petrus de Vries, Daniel F. Dilling, David W. Dunn, Rosmary Ekong, Kevin C. Ess, David Neal Franz, Michael Frost, Zoë Fuchs, Elizabeth S. Gosnell, Lisa M. Guay‐Woodford, Nishant Gupta, Luciana Amaral Haddad, Anne Halbert, Adelaide A. Hebert, Elizabeth P. Henske, Gregory L. Holmes, Dena Hook, John C. Hulbert, Anna Jansen, Simon R. Johnson, Sergiusz Jóźwiak, Bryan H. King, J.C. Kingswood, Timothy K. Knilans, Mary Kay Koenig, Bruce R. Korf, Darcy A. Krueger, David J. Kwiatkowski, Francis X. McCormack, Joel Moss, David Mowat, Kate Mowrey, Rima Nabbout, Mark Nellist, Hope Northrup, Finbar O’Callaghan, Uday Patel, Ashley Pounders, E. Steve Roach, Steven L. Roberds, David Rodriguez‐Buritica, Robb L. Romp, Jonathan Roth, Micaela Rozenberg, Stephen J. Ruoss, Mustafa Şahin, Julian R. Sampson, Joshua Samuels, Matthias Sauter, Catherine Smith, Keyomaurs Soltani, Steven Sparagana, Shoba Srivastava, Clare Stuart, Joyce Teng, Elizabeth A. Thiele, Alexander J. Towbin, Andrew T. Trout, Agnies M. van Eeghen, Stephanie Vanclooster, Henry Z. Wang and 7 more - Pediatric Neurology 2021 cited by 705

  2. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolas Picard, Ron HN van Schaik, Claudia Sommerer, Nils Tore Vethe, Brenda C. M. de Winter, Uwe Christians, Stein Bergan - Therapeutic Drug Monitoring 2019 cited by 654

  3. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation 2019 cited by 331

  4. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Paula Dionisi, Jessica Ryan, Nigel D. Toussaint, Grant Luxton, Chen Au Peh, Vicki Levidiotis, Ross S. Francis, Richard Phoon, Elena Fedosiuk, D.M. Toropilov Toropilov, R. E. Yakubtsevich, Elena Mikhailova, Christophe Bovy, Nathalie Demoulin, Jean‐Michel Hougardy, Bart Maes, Marijn M. Speeckaert, Louis‐Philippe Laurin, Sean Barbour, Mélanie Masse, Michelle Hladunewich, Heather N. Reich, Serge Cournoyer, Karthik Tennankore, Sean Barbour, Jicheng Lv, Zhangsuo Liu, Caili Wang, Shaomei Li, Qun Luo, Zhaohui Ni, Tiekun Yan, Ping Fu, Hong Cheng, Bi‐Cheng Liu, Wanhong Lu, Jianqin Wang, Qinkai Chen, D. Wang, Zuying Xiong, Menghua Chen, Yan Xu, Jiali Wei, Pearl Pai, Lianhua Chen, Jitka Řehořová, Dita Maixnerová, Roman Šafránek, Ivan Rychlík, M Hrubý, Satu Mäkelä, Kati Vääräniemi, Fernanda Ortiz, É. Alamartine, Maïté Daroux, C. Cartery, François Vrtovsnik, Jean‐Emmanuel Serre, Eleni Stamellou, Volker Vielhauer, Christian Hugo, Klemens Budde, Britta Otte, Martin Nitschke, Evangelia Ntounousi, Ioannis Boletis, Αikaterini Papagianni, Dimitrios Goumenos, Kostas Stylianou, Synodi Zermpala and 59 more - Kidney International 2022 cited by 215

  5. Biomarkers in acute kidney injury – pathophysiological basis and clinical performance

    Authors: , , , , - Acta Physiologica 2016 cited by 391

  6. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

    Authors: , , , , , , , , , , , - JAMA 2023 cited by 188

  7. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Transplantation 2014 cited by 526

  8. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christiane M. Erley, Karsten Schlieps, Uwe Kuhlmann, Frans Zandvoort, Bernd Hohenstein, Christian Hugo, Catrin Palm, Karl F. Hilgers, Oliver Witzke, Oliver Groß, Ulf Panzer, Hermann Haller, Anna Bertram, Claudia Sommerer, Martin Zeier, Günter Wolf, Martin Busch, Gunter Wolf, Stephan Ziefle, Thomas Benzing, Franziska Grundmann, Peter R. Mertens, Stefan Westphalen, Urs Benck, Uwe Göttmann, Volker Vielhauer, Michael Fischereder, Oliver Sarkar, Marianna Stefanidou, Johannes F.E. Mann, Britta Otte, Hermann Pavenstädt, Bernhard Banas, A Boeger, Nils Heyne, Ferruh Artunç, Helmut Reichel, Thomas Mettang, Christoph Wanner, Thomas Mettang, Stephanie Wied, Christina Fitzner, R.-D Hilgers, Christina Fitzner, R.-D Hilgers - Kidney International 2020 cited by 202

  9. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 150

  10. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James W. Wheless, Joyce Y. Wu, Thomas N. Darling, Edward W. Cowen, Elizabeth S. Gosnell, Adelaide A. Hebert, Greg Mlynarczyk, Keyomaurs Soltani, Joyce Teng, Mari Wataya‐Kaneda, Patricia M. Witman, Chris Kingswood, John J. Bissler, Klemens Budde, John C. Hulbert, Lisa M. Guay‐Woodford, Julian R. Sampson, Matthias Sauter, Bernard Zonneberg, Sergiusz Jóźwiak, Ute Bartels, Moncef Berhouma, David Neal Franz, Mary Kay Koenig, Darcy A. Krueger, E. Steve Roach, Jonathan Roth, Henry E. Wang, Howard L. Weiner, Francis X. McCormack, Khalid F. Almoosa, Alan S. Brody, Charles D. Burger, Vincent Cottin, Geraldine A. Finlay, Jennifer Glass, Elizabeth P. Henske, Simon R. Johnson, Robert M. Kotloff, D. K. Lynch, Joel Moss, Karen L. Smith, Jay Rhu, Angelo Taveira Da Silva, Lisa R. Young, Timothy K. Knilans, Robert B. Hinton, Ashwin Prakash, Robb L. Romp, Arun D. Singh, Ashish DebRoy, Pei‐Lung Chen, Steven Sparagana, Michael Frost - Pediatric Neurology 2013 cited by 1,508

  11. A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2020 cited by 175

  12. Exploring the Complexity of Death-Censored Kidney Allograft Failure

    Authors: , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 156

  13. An automated histological classification system for precision diagnostics of kidney allografts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nassim Kamar, Oriol Bestard, Arjang Djamali, Klemens Budde, Mark Haas, Carmen Lefaucheur, Marion Rabant, Alexandre Loupy - Nature Medicine 2023 cited by 55

  14. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2013 cited by 879

  15. Autoantibodies against thrombospondin type 1 domain–containing 7A induce membranous nephropathy

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 230

  16. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linda Salzmann, Burkhard Tönshoff, Ron H. N. van Schaik, Nils Tore Vethe, Alexander A. Vinks, Pierre Wallemacq, Anders Åsberg, Loralie J. Langman - Therapeutic Drug Monitoring 2021 cited by 200

  17. Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 99

  18. Donor-derived cell-free DNA as a diagnostic tool in transplantation

    Authors: , , , , , , - Frontiers in Genetics 2022 cited by 83

  19. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Beneyto, David Navarro, Sophie Ohlmann - Trials 2023 cited by 58

  20. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

    Authors: , , , , , , , , , , , , , , , - American Journal of Transplantation 2007 cited by 617

  21. Clinical Outcome Prediction from Admission Notes using Self-Supervised Knowledge Integration

    Authors: , , , , , - Conference of the European Chapter of the Association for Computational Linguistics: Main Volume, EACL 2021 cited by 26

  22. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Köttgen, Albert Ong, Katja Petzold, Yves Pirson, G. Remuzzi, Roser Torrá, Richard Sandford, Andreas L. Serra, Vladimı́r Tesař, Gerd Walz, the WGIKD, Rudolf P. Wüthrich, Corinne Antignac, René J.M. Bindels, Dominique Chauveau, Olivier Devuyst, Francesco Emma, Ron T. Gansevoort, Patrick H. Maxwell, Albert Ong, G. Remuzzi, Pierre Ronco, Franz Schaefer - Nephrology Dialysis Transplantation 2014 cited by 237

  23. Donor–Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation

    Authors: , , , , , , , , , - American Journal of Transplantation 2017 cited by 166

  24. The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation

    Authors: , , , , , , , , , , , , - Genetics in Medicine 2021 cited by 65